Bio-Thera Solutions, News

Biotech voluntarily disclosed an announcement that the marketing license application for BAT2506 (golimumab) injection was accepted by the European EMA

10minutes ago

Announcement of Resolutions of the 17th Meeting of the 2nd Board of Supervisors of Biotech

10minutes ago

Biotech: Biotech voluntarily discloses an announcement regarding the signing of licensing and production, supply and commercialization agreements with Steincares for BAT2306 (scuchiumab) injection

Dec 17, 2024 00:00

Biotech: Announcement of Resolutions of the 20th Meeting of the 2nd Board of Directors of Biotech

Dec 17, 2024 00:00

Announcement of Resolutions of the 20th Meeting of the 2nd Board of Directors of Biotech

Dec 17, 2024 00:00

Biotech voluntarily disclosed an announcement regarding the signing of licensing and production, supply and commercialization agreements with SteinCares for BAT2306 (scuchiumab) injection

Dec 17, 2024 00:00

Biotech Investor Relations Activity Record Form (2024 Third Quarter Results Briefing)

Nov 25, 2024 16:18

Biotech\'s announcement on holding a results briefing for the third quarter of 2024

Nov 13, 2024 00:00

Biotech: Biotech on Gedeon Richter Plc. (Jiri Pharmaceuticals) Announcement on the signing of licensing and production, supply and commercialization agreements for BAT2206 (usinumab) injections

Oct 9, 2024 07:53

Biotech Investor Relations Activity Record Form (2024 Semi-Annual Science and Technology Innovation Board Pharmaceutical and Biological Products Group Performance Briefing)

Sep 18, 2024 17:07

Biotech Investor Activity Record Form (2024 Investor Online Group Reception Day Event in Guangdong Province)

Sep 12, 2024 18:27

Baiaotai\'s announcement on participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products

Sep 10, 2024 00:00

Baiaotai\'s announcement on participating in the 2024 Investor Online Group Reception Day in Guangdong

Sep 10, 2024 00:00

Biotech voluntarily disclosed the notice of approval for dupriumab injection (BAT2406) for drug clinical trials

Aug 31, 2024 00:00

Biotech voluntarily disclosed the notice of approval for clinical trials of BAT8006 combined with bevacizumab

Aug 28, 2024 00:00

China International Finance Co., Ltd.'s verification opinion on the temporary supplementation of working capital using a portion of idle raised funds by Bio-Thera Solutions, Ltd.

Aug 23, 2024 00:00

Bio-Thera Solutions Announcement on the Temporary Supplement of Working Capital Using Part of the Idle Fund Raised

Aug 23, 2024 00:00

Bio-Thera Solutions 's semi-annual assessment report on the special action plan to improve quality and efficiency and return to the report in 2024.

Aug 23, 2024 00:00

Bio-Thera Solutions special report on the deposit and actual use of funds for the first half of 2024.

Aug 23, 2024 00:00

Announcement of the resolution of the 15th meeting of the second board of supervisors of Bio-Thera Solutions

Aug 23, 2024 00:00